MENU

INTS Intensity Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
INTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
INTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INTS is expected to report earnings to rise 10.00% to -27 cents per share on March 13

Intensity Therapeutics INTS Stock Earnings Reports
Q4'24
Est.
$-0.28
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.04
Q4'23
Missed
by $0.05
Q3'23
Missed
by $0.08
The last earnings report on November 13 showed earnings per share of -25 cents, beating the estimate of -35 cents. With 10.45K shares outstanding, the current market capitalization sits at 43.73M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

INTS and Stocks

Correlation & Price change

A.I.dvisor tells us that INTS and GBIO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
+2.42%
GBIO - INTS
29%
Poorly correlated
-8.20%
TSVT - INTS
28%
Poorly correlated
-5.08%
MRKR - INTS
27%
Poorly correlated
-3.85%
CARA - INTS
26%
Poorly correlated
+1.08%
CKPT - INTS
26%
Poorly correlated
+4.42%
More